Table 1.
Group | Dose route | Dose level (mg/kg/dose) | Number of animals | |||
---|---|---|---|---|---|---|
Subgroup 1 | ||||||
Toxicity | Treatment free | |||||
Male | Female | Male | Female | |||
1 | IV | 0 (control) | 10 | 10 | 5 | 5 |
2 | IV | 15 (low) | 10 | 10 | – | – |
3 | IV | 50 (intermediate) | 10 | 10 | – | – |
4 | IV | 150 (high) | 10 | 10 | 5 | 5 |
5 | IM | 2 mg per dose (low) | 10 | 10 | 5 | 5 |
Subgroup 2 | ||||||
---|---|---|---|---|---|---|
Toxicokinetics | ||||||
Male | Female | |||||
1 | IV | 0 (control) | 3 | 3 | ||
2 | IV | 15 (low) | 9 | 9 | ||
3 | IV | 50 (intermediate) | 9 | 9 | ||
4 | IV | 150 (high) | 9 | 9 | ||
5 | IM | 2 mg per dose (low) | 9 | 9 |
Subgroup 3 | ||||||
---|---|---|---|---|---|---|
Hormone | ||||||
Male | Female | |||||
1 | IV | 0 (control) | 5 | 5 | ||
2 | IV | 15 (low) | 5 | 5 | ||
3 | IV | 50 (intermediate) | 5 | 5 | ||
4 | IV | 150 (high) | 5 | 5 | ||
5 | IM | 2 mg per dose (low) | 5 | 5 |
IV intravenous infusion; IM intramuscular injection